Impact of Programmed Death Ligand 1 Expression on Outcomes in Stage I-II Epidermal Growth Factor Receptor-Mutant Lung Adenocarcinoma

Clinical Lung Cancer · Published 2026-04-02 · DOI 10.1016/j.cllc.2026.03.013

Authors being retrieved — see the publisher record. https://doi.org/10.1016/j.cllc.2026.03.013

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Related articles